Market Overview

A Peek Into The Market Before The Trading Starts

Share:
A Peek Into The Market Before The Trading Starts
Related VRA
Concern For Kate Spade Spills Over Into The Rest Of Retail, But Jefferies Remains Bullish
Increased Share Of Internet Search Traffic Could Mean Better Comp Sales For Coach And Kate Spade
Related PIR
At Home Group Shares Selloff Following IPO Open At $16.25
Watch These 7 Huge Put Purchases In Wednesday Trade

Pre-open movers US stock futures are mostly flat this morning, as investors are awaiting economic data. Futures for the Dow Jones Industrial Average dropped 3 points to 13,227.00 and S&P 500 index futures fell 1.70 points to 1,425.50. Nasdaq 100 futures declined 1.50 points to 2,668.75.

A Peek Into Global Markets European markets were lower today. The STOXX Europe 600 Index fell 0.29%, London's FTSE 100 Index dropped 0.25%, French CAC 40 Index declined 0.05% and German DAX 30 index fell 0.32%.

Asian markets ended mostly lower, with Japan's Nikkei Stock Average rising 1.68%, China's Shanghai Composite dropping 1.02% and Australia's S&P/ASX 200 rising 0.02%. Hong Kong's Hang Seng Index fell 0.26% and India's Sensex dropped 0.65%.

Broker Recommendation Analysts at Jefferies upgraded Vera Bradley (NASDAQ: VRA) from “hold” to “buy.” The target price for Vera Bradley has been raised from $22 to $35.

Vera Bradley shares gained 1.41% to $24.48 in pre-market trading.

Breaking news

  • Pier 1 Imports (NYSE: PIR) reported a 3% rise in its fiscal third-quarter earnings and lifted its full-year earnings forecast. To read the full news, click here.
  • International Game Technology (NYSE: IGT) today announced it has agreed to a deal to provide mobile games to Paddy Power in a significant extension to the companies' existing partnership. To read the full news, click here.
  • Oncolytics Biotech (NASDAQ: ONCY) today announced initial positive top line data from the first endpoint in its double-blinded randomized Phase III clinical study examining REOLYSIN in combination with carboplatin and paclitaxel in second-line patients with platinum-refractory, taxane-naïve head and neck cancers (REO 018). To read the full news, click here.
  • ReachLocal (NASDAQ: RLOC) today announced that its Board of Directors has amended its previously announced share repurchase program to increase the total authorized repurchase amount by $6 million, to a total authorization of $26 million. To read the full news, click here.

Posted-In: Jefferies US Stock FuturesNews Futures Global Pre-Market Outlook Markets

 

Related Articles (ONCY + IGT)

View Comments and Join the Discussion!